JRCT ID: jRCT1032210196
Registered date:14/07/2021
ROBOCOLO study
Basic Information
Recruitment status | Complete |
---|---|
Health condition(s) or Problem(s) studied | Health Condition(s) or Problem(s) Studied Colon cancer |
Date of first enrollment | 24/08/2021 |
Target sample size | 41 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | Robotic right-hemicolectomy |
Outcome(s)
Primary Outcome | Postoperative complications within 30 days after surgery |
---|---|
Secondary Outcome | 1. Conversion rate 2. Readmission rate within 30 days after surgery 3. Mortality rate within 30 days after surgery 4. Intraoperative adverse events (vascular damage / organ damage / reconstruction / other) 5. Postoperative recovery (postoperative hospital stay, time to first flatus, time to first oral intake) 6. Surgical results (blood loss, operative time, console time, harvested lymph node number, R0 resection rate) |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | 1. Patients over 20 years old age 2. Histologically, diagnosed with colon cancer 3. Preoperative diagnosis of curative primary resection 4. Main tumor site is cecum (C), ascending colon (A) or right-sided transverse colon (T) and right-hemicolectomy with D2 or higher lymph node dissection is pre-planned 5. Clinical stage I to IIIC (T1-4b, N0-2b, M0: TNM Classification) has been diagnosed 6. Patients who are diagnosed out of the endoscopic resection 7. Patients with tumor maximum diameter of 8 cm or less 8. Patients who do not recognize multiple lesions that require two or more anastomosis places 9. Patients with ECOG Performance Status (PS) score of 0 to 1 10. Patients who have the judgment to fully understand the research content. 11. Patients with written informed consent to participate in this study. |
Exclude criteria | 1. Patients with chemotherapy (systemic anti-cancer drug treatment) and a history of radiation therapy, including treatment for other cancer species. 2. Patients who have a history of open surgery 3. Patients who have a history of laparoscopic stomach resection or colectomy 4. Patients with the latest check values within 14 days before registration meet the following Leukocyte <3000 / mm 3, Platelet <75,000 / mm 3, Hemoglobin <7 G / DL, AST> 100 IU / L, ALT> 100 IU / L, Serum Cr> 1.5 mg / dl. 5. Other patients who are judged to be unsuitable as a subject by the doctor's judgment. |
Related Information
Primary Sponsor | Ishibe Atsushi |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) |
Contact
Public contact | |
Name | Jun Watanabe |
Address | 4-57 Urafune, Minami-ku, Yokohama Kanagawa Japan 232-0024 |
Telephone | +81-45-261-5656 |
jun0926@yokohama-cu.ac.jp | |
Affiliation | Yokohama City University Medical Center |
Scientific contact | |
Name | Atsushi Ishibe |
Address | 3-9 Fukuura, Kanazawa-ku, Yokohama Kanagawa Japan 236-0004 |
Telephone | +81-45-787-2800 |
aishibe@yokohama-cu.ac.jp | |
Affiliation | Yokohama City University Hospital |